T. Rowe Price Associates’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
78,278
+17,353
+28% +$372K ﹤0.01% 2003
2025
Q4
$1.56M Sell
60,925
-6,429
-10% -$148K ﹤0.01% 1870
2025
Q3
$1.45M Buy
67,354
+8,302
+14% +$189K ﹤0.01% 1886
2025
Q2
$1.3M Buy
59,052
+3,853
+7% +$84.5K ﹤0.01% 1851
2025
Q1
$1.23M Sell
55,199
-3,934
-7% -$84.7K ﹤0.01% 1846
2024
Q4
$1.02M Sell
59,133
-130
-0.2% -$2.02K ﹤0.01% 1956
2024
Q3
$994K Buy
59,263
+443
+0.8% +$10.6K ﹤0.01% 1974
2024
Q2
$1.68M Buy
58,820
+3,908
+7% +$118K ﹤0.01% 1643
2024
Q1
$2.1M Buy
54,912
+2,947
+6% +$111K ﹤0.01% 1543
2023
Q4
$1.93M Buy
51,965
+3,189
+7% +$107K ﹤0.01% 1554
2023
Q3
$1.66M Sell
48,776
-33,320
-41% -$1.26M ﹤0.01% 1551
2023
Q2
$3.23M Buy
82,096
+38,989
+90% +$1.41M ﹤0.01% 1322
2023
Q1
$1.39M Buy
43,107
+2,496
+6% +$82.4K ﹤0.01% 1625
2022
Q4
$1.26M Buy
40,611
+4,398
+12% +$159K ﹤0.01% 1654
2022
Q3
$1.34M Buy
36,213
+4,862
+16% +$182K ﹤0.01% 1611
2022
Q2
$911K Buy
31,351
+4,156
+15% +$149K ﹤0.01% 1943
2022
Q1
$1.4M Sell
27,195
-9,899
-27% -$424K ﹤0.01% 1839
2021
Q4
$1.87M Buy
37,094
+16,798
+83% +$940K ﹤0.01% 1746
2021
Q3
$1.14M Sell
20,296
-14,774
-42% -$816K ﹤0.01% 1994
2021
Q2
$2.07M Buy
35,070
+20,955
+148% +$1.18M ﹤0.01% 1724
2021
Q1
$628K Sell
14,115
-11,861
-46% -$554K ﹤0.01% 2255
2020
Q4
$1.1M Sell
25,976
-30,030
-54% -$977K ﹤0.01% 1894
2020
Q3
$1.65M Buy
+56,006
New +$1.54M ﹤0.01% 1607

Other funds holding PGNY

T. Rowe Price Associates's PGNY Position: Q1 2026 in Review

T. Rowe Price Associates increased its Progyny (PGNY) stake by 28% in Q1 2026, buying an estimated $372K and bringing the position to 78,278 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

T. Rowe Price Associates first reported a position in PGNY in Q3 2020 and has held it in 23 quarters since. The position peaked at $3.23M in Q2 2023. 292 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • T. Rowe Price Associates held 78,278 shares of Progyny worth $1.33M as of Q1 2026.
  • T. Rowe Price Associates bought 17,353 Progyny shares in Q1 2026, an estimated $372K.
  • Progyny made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2003 holding.
  • T. Rowe Price Associates first reported a position in Progyny in Q3 2020 and has held it in 23 quarters since.
  • T. Rowe Price Associates's Progyny position peaked at $3.23M in Q2 2023.
  • 292 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.